IPA holds 7th global pharma quality summit; focus is on sustainability

Hyderabad IPA has hosted its 7th Global Pharmaceutical Quality Summit in Mumbai recently. The event brought together leaders from the industry, regulatory agencies, academia and subject experts from across the globe to facilitate discussions on "Making quality pharmaceuticals in India, sustainably, for the world".

The first day highlighted the importance of sustainable operations in pursuit of quality excellence and strategies that will enable our pharmaceutical industry scale the pedestal of a global ladder.

In her keynote address, S Aparna, Secretary, Department of Pharmaceutical said, "It is imperative that we maintain the trust and credibility the pharmaceutical industry enjoys today.

Quality and affordability need to be complemented by innovation and modernity. It is pertinent that the regulators and stakeholders are aligned to improve access to quality healthcare."

Dr V G Somani, Drugs Controller General of India, iterated that he was happy to see the quality summit becoming global. He said, "Covid-19 has been challenging and India has demonstrated its commitment in drug delivery, vaccine supplies by collaborating with relevant stakeholders."

While setting the context of the summit, Sudarshan Jain, Secretary-General, IPA, said "IPA has been organising the Quality Summit from the year 2016 and has consistently been working towards pursuing quality excellence. This year's focus is on sustainability as it is the key to a better future."

"Achieving quality excellence and improving patient centricity in pharmaceutical operations has always been a priority for the Indian pharmaceutical industry. The industry should evolve from 'Make in India' to 'Make and Discover in India' and making quality pharmaceuticals in India, sustainably, for the world," Samir Mehta, President, Indian Pharmaceutical Alliance, said.